Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...

It is also planning a late-stage study in lupus nephritis in a bid to match Benlysta, as well as trials in cutaneous lupus erythematosus and myositis. HHS cancels funding for Moderna's pandemic ...

Most of us will be faced with the need for surgery at some point in our lives. Surgery may present some particular challenges in people who have lupus, so proper preparation is important. Although we ...

May 14, 2025 — Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study shows. The finding ...